Nils Mülling

9PUBLICATIONS
35CO-AUTHORS
Pacific Peoples sport and physical activityCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 26, 2026
Long-term persistence of pneumococcal antibodies 5 years after a sequential PCV13 and PPSV23 vaccination in kidney transplant recipients: indications for revaccination.

Lukas van de Sand, Monika Lindemann, Kim L Völk

|Jan 19, 2026
Cell cycle arrest enhances CD8+ T cell effector function by potentiating glucose metabolism and IL-2 signaling.

Floortje J van Haften, Tetje C van der Sluis, Hanna S Hepp

|Nov 26, 2024
Sequential Vaccination Against Streptococcus pneumoniae Appears as Immunologically Safe in Clinically Stable Kidney Transplant Recipients.

Monika Lindemann, Lukas van de Sand, Nils Mülling

|Jul 08, 2022
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection.

Iris N Pardieck, Tetje C van der Sluis, Esmé T I van der Gracht

|Jan 17, 2022
Predictive role of fluctuating biochemical parameters for mortality in hemodialysis patients.

Nils Mülling, Jan Ter Huurne, Anna Lena Kahl

|Dec 28, 2021
Establishment of an ELISpot Assay to Detect Cellular Immunity against S. pneumoniae in Vaccinated Kidney Transplant Recipients.

Anja Gäckler, Nils Mülling, Kim Völk

Pageof 2

Frequent Collaborators

4 joint publications

Monika Lindemann

2 joint publications

Adalbert Krawczyk

2 joint publications

Tetje C van der Sluis

2 joint publications

Suzanne van Duikeren